3Levey A S, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation,classifi- cation, and stratification [ J ]. Annals of internal medicine, 2003, 139(2) : 137-147. 被引量：1
4Dalla Vestra M, Sailer A, Bortoloso E, et al. Structural involvement in type 1 and type 2 diabetic nephropathy [ J ]. Diabetes & metabolism, 2000,26: 8-14. 被引量：1
5Aumailley M. Structure and supramolecular organization of base- ment membranes[ J]. Kidney international. Supplement, 1995,49:4. 被引量：1
6HOUSE A A,ELIASZIW M,CATFRAN D C,et al. Effect of B-vi- tamin therapy on progression of diabetic nephropathy: a random- ized controlled trial[ J ]. Jama, 2010,303 ( 16 ) : 1603-1609. 被引量：1
7SABOUNJIAN L A, SHIPLEY J, BRAMAN V, et al. Design and Rationale for Randomized, Doubleblind, Placebo-Contro|led Phase 2 Study to Evaluate the Safety and Etficacy of CTP-499 in Patients With Diabetic Nephropathy (DN)[J]. Advances in Chronic Kid-ney Disease,2012,19(2):123. 被引量：1
8ZHANG M Z, WANG S, YANG S, et al. Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS - / - db/db mice [ J ]. American Journal of Physiology-Renal Physiology, 2012,302(4) : F433. 被引量：1
9Fdmjehdehi P, Pakfetrat M, Javidnia K, et al. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-13 and inter|eukin-$ levels in patients with overt type 2 diabetic nephropathy: a randomized, d~uble-blind and placebo-controlled study[J]. Scand J Urol Nephrol, 2011,45(5) : 365-370. 被引量：1
10Pistrosch F, Passauer J, Herbrig K, et al. Effect of thiazolidinedione treatment on proteinuria and renal hemodynamic in type 2 diabetic patients with overt nephropathy[Jl. Horm Metab Res, 2012, 44( 12): 914-918. 被引量：1
